EGFR and lung cancer: Among the studied chemokines and cytokines, IL-6, which was reported to induce EGFR-TKI resistance in EGFR-mutant lung cancer through paracrine STAT3 activation, was highly expressed in EGFR wild-type A549 cells in our study [23].